Anti-CD19 CAR-T cells: Digging in the dark side of the golden therapy-Reference-Cited by-同舟云学术

Anti-CD19 CAR-T cells: Digging in the dark side of the golden therapy

Published:2021-01 Issue: Volume:157 Page:103096
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Bouziana Stella,Bouzianas Dimitrios

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference160 articles.

1. Updated safety and long term clinical outcomes in TRANSCEND NHL 001, pivotal trial of lisocabtagene maraleucel (JCAR017) in R/R aggressive NHL;Abramson;J. Clin. Oncol.,2018

2. Strategies to address chimeric antigen receptor tonic signaling;Ajina;Mol. Cancer Ther.,2018

3. CAR T-cells for T-cell malignancies: challenges in distinguishing between therapeutic, normal, and neoplastic T-cells;Alcantara;Leukemia,2018

4. The european medicines agency review of kymriah (Tisagenlecleucel) for the treatment of acute lymphoblastic leukemia and diffuse large B-Cell lymphoma;Ali;Oncologist,2020

5. IL15 enhances CAR-T cell antitumor activity by reducing mTORC1 activity and preserving their stem cell memory phenotype;Alizadeh;Cancer Immunol. Res.,2019

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Current Landscape of Secondary Malignancies after CAR T-Cell Therapies: How Could Malignancies Be Prevented?;International Journal of Molecular Sciences;2024-09-01

2. Unveiling the PDK4-centered rituximab-resistant mechanism in DLBCL: the potential of the “Smart” exosome nanoparticle therapy;Molecular Cancer;2024-07-15

3. Recent Updates on Chimeric Antigen Receptor T-Cell Approaches in Cancer Immunotherapy;Advances in Cancer Immunotherapy [Working Title];2024-05-15

4. Editorial: Novel insights into CAR T-cell associated neurotoxicity;Frontiers in Neurology;2023-11-07

5. Chimeric Antigen Receptor T Cells: Immunotherapy for the Treatment of Leukemia, Lymphoma, and Myeloma;Molecular Cancer Therapeutics;2023-08-18